British Journal of Cancer - Table of Contents alert Volume 113 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 3 (365-568) Published online 28 July 2015 In this issue Minireview Review Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free.  Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer  Web Focus on Melanoma, the Great Leap Forward   Web Focus on New Drugs to Watch Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction   Minireview Top The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours S J Thomas, J A Snowden, M P Zeidler and S J Danson Br J Cancer 2015 113: 365-371; advance online publication, July 7, 2015; 10.1038/bjc.2015.233 Abstract | Full Text Review Top Clinical utility of RASSF1A methylation in human malignancies A M Grawenda and E O'Neill Br J Cancer 2015 113: 372-381; advance online publication, July 9, 2015; 10.1038/bjc.2015.221 Abstract | Full Text Clinical Studies Top Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort J Cuzick, S Stone, G Fisher, Z H Yang, B V North, D M Berney, L Beltran, D Greenberg, H Møller, J E Reid, A Gutin, J S Lanchbury, M Brawer and P Scardino on behalf of the Transatlantic Prostate Group Br J Cancer 2015 113: 382-389; advance online publication, June 23, 2015; 10.1038/bjc.2015.223 Abstract | Full Text Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study B Yeo, L Zabaglo, M Hills, A Dodson, I Smith and M Dowsett Br J Cancer 2015 113: 390-395; advance online publication, July 16, 2015; 10.1038/bjc.2015.222 Abstract | Full Text Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer Ruud van der Noll, Serena Marchetti, Neeltje Steeghs, Jos H Beijnen, Marja W J Mergui-Roelvink, Emmy Harms, Harriet Rehorst, Gabe S Sonke and Jan H M Schellens Br J Cancer 2015 113: 396-402; advance online publication, July 16, 2015; 10.1038/bjc.2015.256 Abstract | Full Text Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another? M M J Zanders, M P P van Herk-Sukel, P A J Vissers, R M C Herings, H R Haak and L V van de Poll-Franse Br J Cancer 2015 113: 403-410; advance online publication, July 16, 2015; 10.1038/bjc.2015.259 Abstract | Full Text Translational Therapeutics Top Frequent PD-L1 expression in testicular germ cell tumors C D Fankhauser, A Curioni-Fontecedro, V Allmann, J Beyer, V Tischler, T Sulser, H Moch and P K Bode Br J Cancer 2015 113: 411-413; advance online publication, July 14, 2015; 10.1038/bjc.2015.244 Abstract | Full Text Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer K-F Hsu, M-R Shen, Y-F Huang, Y-M Cheng, S-H Lin, N-H Chow, S-W Cheng, C-Y Chou and C-L Ho Br J Cancer 2015 113: 414-424; advance online publication, July 9, 2015; 10.1038/bjc.2015.254 Abstract | Full Text BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts I Lohse, A Borgida, P Cao, M Cheung, M Pintilie, T Bianco, S Holter, E Ibrahimov, R Kumareswaran, R G Bristow, M-S Tsao, S Gallinger and D W Hedley Br J Cancer 2015 113: 425-432; advance online publication, July 16, 2015; 10.1038/bjc.2015.220 Abstract | Full Text Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis Rie Natatsuka, Tsuyoshi Takahashi, Satoshi Serada, Minoru Fujimoto, Tomohiro Ookawara, Toshirou Nishida, Hisashi Hara, Takahiko Nishigaki, Emi Harada, Takashi Murakami, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Hiroshi Miyata, Kiyokazu Nakajima, Shuji Takiguchi, Tadamitsu Kishimoto, Masaki Mori, Yuichiro Doki and Tetsuji Naka Br J Cancer 2015 113: 433-442; advance online publication, July 16, 2015; 10.1038/bjc.2015.229 Abstract | Full Text Molecular Diagnostics Top Bone marrow-derived stromal cells are associated with gastric cancer progression H Kasashima, M Yashiro, H Nakamae, G Masuda, H Kinoshita, T Morisaki, T Fukuoka, T Hasegawa, K Sakurai, T Toyokawa, N Kubo, H Tanaka, K Muguruma, M Ohira, T Nakane, M Hino and K Hirakawa Br J Cancer 2015 113: 443-452; advance online publication, June 30, 2015; 10.1038/bjc.2015.236 Abstract | Full Text Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer W L Santivasi, H Wang, T Wang, Q Yang, X Mo, E Brogi, B G Haffty, A B Chakravarthy and Fen Xia Br J Cancer 2015 113: 453-459; advance online publication, June 9, 2015; 10.1038/bjc.2015.208 Abstract | Full Text Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease I M Reis, K Ramachandran, C Speer, E Gordian and R Singal Br J Cancer 2015 113: 460-468; advance online publication, July 14, 2015; 10.1038/bjc.2015.240 Abstract | Full Text Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins A Khadjavi, F Mannu, P Destefanis, C Sacerdote, A Battaglia, M Allasia, D Fontana, B Frea, S Polidoro, G Fiorito, G Matullo, A Pantaleo, A Notarpietro, M Prato, F Castagno, P Vineis, P Gontero, G Giribaldi and F Turrini Br J Cancer 2015 113: 469-475; advance online publication, June 30, 2015; 10.1038/bjc.2015.232 Abstract | Full Text Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease A Szpechcinski, J Chorostowska-Wynimko, R Struniawski, W Kupis, P Rudzinski, R Langfort, E Puscinska, P Bielen, P Sliwinski and T Orlowski Br J Cancer 2015 113: 476-483; advance online publication, June 30, 2015; 10.1038/bjc.2015.225 Abstract | Full Text Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer D Korbakis, A Dimitromanolakis, I Prassas, G J Davis, E Barber, K L Reckamp, I Blasutig and E P Diamandis Br J Cancer 2015 113: 484-491; advance online publication, July 16, 2015; 10.1038/bjc.2015.171 Abstract | Full Text Tumour-suppressive function of SIRT4 in human colorectal cancer M Miyo, H Yamamoto, M Konno, H Colvin, N Nishida, J Koseki, K Kawamoto, H Ogawa, A Hamabe, M Uemura, J Nishimura, T Hata, I Takemasa, T Mizushima, Y Doki, M Mori and H Ishii Br J Cancer 2015 113: 492-499; advance online publication, June 18, 2015; 10.1038/bjc.2015.226 Abstract | Full Text Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis L De Smedt, J Lemahieu, S Palmans, O Govaere, T Tousseyn, E Van Cutsem, H Prenen, S Tejpar, M Spaepen, G Matthijs, C Decaestecker, X Moles Lopez, P Demetter, I Salmon and X Sagaert Br J Cancer 2015 113: 500-509; advance online publication, June 11, 2015; 10.1038/bjc.2015.213 Abstract | Full Text Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas—an immunohistochemical study M Weber, P Moebius, M Büttner-Herold, K Amann, R Preidl, F W Neukam and F Wehrhan Br J Cancer 2015 113: 510-519; advance online publication, June 25, 2015; 10.1038/bjc.2015.212 Abstract | Full Text Epidemiology Top Personal history of rosacea and risk of incident cancer among women in the US W-Q Li, M Zhang, F W Danby, J Han and A A Qureshi Br J Cancer 2015 113: 520-523; advance online publication, June 23, 2015; 10.1038/bjc.2015.217 Abstract | Full Text Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case–control study in Kashmir, India G A Bhat, I A Shah, R Rafiq, S Nabi, B Iqbal, M M Lone, F Islami, P Boffetta and N A Dar Br J Cancer 2015 113: 524-532; advance online publication, June 30, 2015; 10.1038/bjc.2015.218 Abstract | Full Text Cancer symptom awareness and barriers to symptomatic presentation in England—are we clear on cancer? M Niksic, B Rachet, F G Warburton, J Wardle, A J Ramirez and L J L Forbes Br J Cancer 2015 113: 533-542; advance online publication, June 30, 2015; 10.1038/bjc.2015.164 Abstract | Full Text Early-stage breast cancer is not associated with the risk of marital dissolution in a large prospective study of women V S Laitala, T Saarto, E K Einiö, P Martikainen and K Silventoinen Br J Cancer 2015 113: 543-547; advance online publication, July 16, 2015; 10.1038/bjc.2015.216 Abstract | Full Text Ethnicity, deprivation and screening: survival from breast cancer among screening-eligible women in the West Midlands diagnosed from 1989 to 2011 M Morris, L M Woods, N Rogers, E O'Sullivan, O Kearins and B Rachet Br J Cancer 2015 113: 548-555; advance online publication, June 16, 2015; 10.1038/bjc.2015.204 Abstract | Full Text Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland D Mansouri, D C McMillan, C Crearie, D S Morrison, E M Crighton and P G Horgan Br J Cancer 2015 113: 556-561; advance online publication, July 9, 2015; 10.1038/bjc.2015.230 Abstract | Full Text Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study H Arem, Y Park, A S Felix, A Zervoudakis, L A Brinton, C E Matthews and M J Gunter Br J Cancer 2015 113: 562-568; advance online publication, June 23, 2015; 10.1038/bjc.2015.224 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.